Search Results 1611-1620 of 12569 for transexamic

  1. Publications - Richard G. Frimpong, M.D. - Mayo Clinic

    Richard, Takahashi Edwin. Comparison of Short-Term Infectious Rates Related to Implantable Venous Port Placement With and Without Prophylactic Antibiotic ...

  2. ABSORB III Randomized Controlled Trial (RCT) - Mayo Clinic

    The ABSORB III RCT is a prospective randomized, single-blind, multi-center trial. It is the pivotal trial to support the US pre-market approval (PMA) of Absorb™ ...

  3. Publications - Zech G. Franks, M.D. - Mayo Clinic

    Franks ZG, Nandakumar K, Santhanam L, Lester L, Walsh JM, Dalesio NM. ACE2 and TAS2R38 receptor expression in pediatric and adult patients in the nasal and ...

  4. Publications - Terry C. Burns, M.D., Ph.D. - Mayo Clinic

    Personalized Tumor-Specific Amplified DNA Junctions in Peripheral Blood of Patients with High-Grade Gliomas. Clin Cancer Res. 2025 May 01; 31(9):1700-1710. View ...

  5. Moxetumomab pasudotox-tdfk (intravenous route) - Side effects & uses - Mayo Clinic

    Moxetumomab pasudotox-tdfk injection is used to treat hairy cell leukemia that has worsened or cannot be completely removed in patients who have had at least ...

  6. Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation - Mayo Clinic

    The purpose of this study is to evaluate the safety and effectiveness of the Tendyne™ Mitral Valve System for the treatment of patients with symptomatic, ...

  7. A Phase 1b/2 Study of Onvansertib (PCM-075) in Combination with FOLFIRI and Bevacizumab for Second-Line Treatment of Metastatic Colorectal Cancer in Patients with a KRAS Mutation - Mayo Clinic

    Participants must have histologically confirmed metastatic and unresectable disease, and previously failed treatment or be intolerant to fluoropyrimidine and ...

  8. Phase 2 Study to Evaluate Safety and Efficacy of RM-131 Administered to Patients With Chronic Constipation - Mayo Clinic

    The purpose of this study is to evaluate safety and tolerability as well as the effects of RM-131 on colonic transit, bowel consistency, bowel habits, abdominal ...

  9. A Study of GDC-0449 and Erlotinib Hydrochloride, with or without Gemcitabine Hydrochloride for Treating Patients with Metastatic Pancreatic Cancer or Solid Tumors that cannot be Removed by Surgery - Mayo Clinic

    Drugs used in chemotherapy, such as GDC-0449 and gemcitabine hydrochloride, work in different ways to stop the growth of tumor cells, either by killing the ...

  10. https://www.mayoclinic.org/~/media/FD382661FD544C6CB4A38FC785855FAB